PROFNAIT is a collaborative project with participation of eleven Northern European hospitals, blood banks and companies with key expertises in FNAIT and drug development and manufacturing.
All project participants comply with the highest safety standards. The clinical studies will be approved by the national ethical committees and follow the European Medicines Agency’s guidelines.
Together we strive to develop and prove the safety and efficacy of this novel treatment of FNAIT and to bring it to the mothers at risk of having a baby/newborn with FNAIT.
PROFNAIT consortium members:
The PROFNAIT team was assembled at the project kick-off meeting in Copenhagen, August 2012 during which a group photo was taken.
(Click to enlarge image)